Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Benzyl benzoate adverse reaction (disorder) |
Causative agent (attribute) |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to benzyl benzoate |
Causative agent (attribute) |
False |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzyl benzoate 25% application BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzyl penicilloyl-polylysin 0.06mmo injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzyl benzoate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection solution 0.25mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to benzyl benzoate |
Causative agent (attribute) |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing benzyl benzoate in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzyl benzoate-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzyl benzoate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzyl benzoate only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzyl benzoate 250 mg/mL cutaneous emulsion |
Has basis of strength substance (attribute) |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzyl benzoate 250 mg/mL cutaneous emulsion |
Has precise active ingredient |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely benzyl benzoate 225 milligram/1 gram and disulfiram 20 milligram/1 gram conventional release cutaneous emulsion (clinical drug) |
Has precise active ingredient |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely benzyl benzoate 225 milligram/1 gram and disulfiram 20 milligram/1 gram conventional release cutaneous emulsion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benzyl benzoate and disulfiram only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only benzyl benzoate and disulfiram in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benzyl benzoate- and disulfiram-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing benzyl benzoate and disulfiram in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzyl benzoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |